The Risk of Serious Infections with Mirikizumab versus Other Biologics among Patients with Ulcerative Colitis: A Secondary Database Study in Japan

First published 15/10/2024

Last updated 15/10/2024

EU PAS number:

EUPAS1000000338

Study

Planned

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

The Risk of Serious Infections with Mirikizumab versus Other Biologics among Patients with Ulcerative Colitis: A Secondary Database Study in Japan

Secondary tabs

Share this page